Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality

American Journal of Medicine

Volumn 103, Issue 5, 1997, Pages 368-375

  McCullough, Peter A ^a,b   Wolyn, Robert ^a   Rocher, Leslie L ^a   Levin, Robert N ^a   O'Neill, William W ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; CREATININE; DIATRIZOATE; GLUCOSE; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; UREA;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; ATHERECTOMY; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIPLE REGRESSION; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; STENT; SURVIVAL TIME;

AGED; AGED, 80 AND OVER; BLOOD UREA NITROGEN; CONTRAST MEDIA; CORONARY DISEASE; CREATININE; DIABETES COMPLICATIONS; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STROKE VOLUME;

EID: 0030661687     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00150-2     Document Type: Article

References (54)

1. Hou SH, Bushinsky DA, Wish JB, et al. Hospital-acquired renal insufficiency: a prospective study. Am J Med. 1983;74:243-248.
2. Chertow GM, Christiansen CL, Cleary PD, et al. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med. 1995;155:1505-1511.
3. Joachimsson PO, Stahle E, Nystrom SO, Tyden H. Incidence of acute renal failure in open heart surgery. J Cardiothorac Anesth. 1989;3:58.
4. Spiegel DM, Ullian ME, Zerbe GO, Berl T. Determinants of survival and recovery in acute renal failure patients dialyzed in intensive-care units. Am J Nephrol. 1991;11:44-47.
5. Zanardo G, Michielon P, Paccagnella A, et al. Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg. 1994;107:1489-1495.
6. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality. A cohort analysis. JAMA. 1996;275:1489-1494.
7. Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative renal risk stratification. Circulation 1997;95:878-884.
8. Shusterman N, Strom BL, Murray TG, et al. Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study. Am J Med. 1987;83:65-71.
9. Lohr JW, McFarlane MJ, Grantham JJ. A clinical index to predict survival in acute renal failure patients requiring dialysis. Am J Kidney Dis. 1988;11:254-259.
10. Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med. 1990;150:1237-1242.
11. Taliercio CP, Vlietstra RE, Fisher LD, Burnett JC. Risks for renal dysfunction with cardiac angiography. Ann Intern Med. 1986;104:501-504.
12. Cochran ST, Wong WS, Roe DJ. Predicting angiography-induced acute renal function impairment: clinical risk model. Am J Roentgenol. 1983;141:1027-1033.
13. Weinrauch LA, Healy RW, Leland OS, Jr., et al. Coronary angiography and acute renal failure in diabetic azotemic nephropathy. Ann Intern Med. 1977;86:56-59.
14. Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med. 1990;89:615-620.
15. Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 1989;86:649-652.
16. Davidson CJ, Hlatky M, Morris KG, et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med. 1989;110:119-124.
17. Hill JA, Winniford M, Cohen MB, et al. Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. The lohexol Cooperative Study. Am J Cardiol. 1993;72:770-775.
18. Kahn JK, Rutherford BD, McConahay DR, et al. High-dose contrast agent administration during complex coronary angioplasty. Am Heart J. 1990;120:533-536.
19. Barrett BJ, Parfrey PS, Vavasour HM, et al. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int. 1992;41:1274-1279.
20. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. NEJM. 1989;320:143-149.
21. Schwab SJ, Hlatky MA, Pieper KS, et al. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. NEJM. 1989;320:149-153.
22. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. NEJM. 1994;331:1416-1420.
23. Spiegel DM, Breyer JA. Serum albumin: a predictor of long-term outcome in peritoneal dialysis patients. An J Kidney Dis. 1994;23:283-285.
24. Spiegel DM, Anderson M, Campbell U, et al. Serum albumin: a marker for morbidity in peritoneal dialysis patients. Am J Kidney Dis. 1993;21:26-30.
25. Weinstein JM, Heyman S, Brezis M. Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron. 1992;62:413-415.
26. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The lohexol Cooperative Study. Kidney Int. 1995;47:254-261.
27. Weisberg LS, Kurnik PB, Kurnik BR. Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans. Ren Fail. 1993; 15:61-68.
28. Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int. 1994;45:259-265.
29. Ritchie JL, Nissen SE, Douglas JS, Jr., et al. Use of nonionic or low osmolar contrast agents in cardiovascular procedures. J Am Coll Cardiol. 1993;21: 269-273.
30. Nagappan R, Williams LC, List AR. Acute renal failure due to low osmolar radiographic contrast medium. N Z Med J. 1993;106:388-389.
31. Steinberg EP, Moore RD, Powe NR, et al. Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography. NEJM. 1992;326:425-430.
32. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high-and low-osmolality iodinated contrast media. Radiology. 1993;188:171-178.
33. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism -a critical review. Am J Kidney Dis. 1994;24:713-727.
34. Porter GA. Contrast medium-associated nephropathy. Recognition and management. Invest Radiol. 1993;28(Suppl 4):S11-S18.
35. Gomes AS, Baker JD, Martin-Paredero V, et al. Acute renal dysfunction after major arteriography. Am J Roentgenol. 1985;145:1249-1253.
36. Erley CM, Duda SH, Schlepckow S, et al. Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int. 1994;45:1425-1431.
37. Tommaso CL. Contrast-induced nephrotoxicity in patients undergoing cardiac catheterization. Cathet Cardiovasc Diagn. 1994;31:316-321.
38. Margulies K, Schirger J, Burnett J, Jr. Radiocontrast-induced nephropathy: current status and future prospects. Int Angiol. 1992;11:20-25.
39. Barrett BJ. Contrast nephrotoxicity [editorial]. J Am Soc Nephrol. 1994;5:125-137.
40. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039.
41. WHO Expert Committee on Diabetes Mellitus. Second report. WHO Tech Rep Ser. 1980;646:9.
42. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
43. Berns JS, Rudnick MR. Radiocontrast media associated nephrotoxicity. Kidney. 1992;24:1-6.
44. de Haan MW, Kouwenhoven M, Thelissen RP, et al. Renovascular disease in patients with hypertension: detection with systolic and diastolic gating in three-dimensional, phase-contrast MR angiography. Radiology. 1996;198: 449-456.
45. Andersson LG, Ekroth R, Bratteby LE, et al. Acute renal failure after coronary surgery - a study of incidence and risk factors in 2009 consecutive patients. Thorac Cardiovasc Surgeon. 1993;41:237-241.
46. Hosmer DW, Lemeshow S. Assessing the fit of the model. In: Applied Logistic Regression. New York: John Wiley and Sons, 1989;135-173.
47. King BF, Hartman GW, Williamson B, Jr. Low-osmolality contrast media: a current perspective. Mayo Clin Proc. 1989;64:976-985.
48. Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47:186-192.
49. Nunez BD, Allon M: Effect of cardiac catheterization on renal function. Clin Nephrol. 1990;34:263-266.
50. Vlietstra RE, Nunn CM, Navarte J, Browne KF: Contrast nephropathy after coronary angioplasty in chronic renal insufficiency. Am Heart J. 1996;132: 1049-1050.
51. Grines CL, Schreiber TL, Savas V, et al. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1996;27:1381-1386.
52. Porter GA. Contrast-associated nephropathy: presentation, pathophysiology and management. Miner Electrolyte Metab. 1994;20:232-243.
53. D'Elia JA, Gleason RE, Alday M, et al. Nephrotoxicity from angiographic contrast material. A prospective study. Am J Med. 1982;72:719-725.
54. Teruel JL, Marcen R, Onaindia JM, et al. Renal function impairment caused by intravenous urography. A prospective study. Arch Intern Med. 1981;141:1271-1274.